Contact
Please use this form to send email to PR contact of this press release:
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
TO:
Please use this form to send email to PR contact of this press release:
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
TO: